Theravance Biopharma, Inc. Highlights 2022 Accomplishments And 2023 Key Targets; Said Seeks To Achieve Non-GAAP1 Profitability By 2H 2023
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced its 2022 Accomplishments and 2023 Key Targets.